MRX-4 + omeprazole

MRX-4 + omeprazole is a combination drug consisting of two components: - **MRX-4** (identity and mechanism not established in available sources; likely an investigational or code-named compound) - **Omeprazole**, a well-established proton pump inhibitor that reduces gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells. Omeprazole is used to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcer disease, erosive esophagitis, and for Helicobacter pylori eradication when combined with antibiotics[1][2][5][6]. The combination may be intended for gastrointestinal indications where acid suppression is beneficial, but no specific clinical data or regulatory status for "MRX-4 + omeprazole" as a fixed-dose product could be identified.